PwPepwise

Epitalon

Anti-Aging & Longevity

a.k.a. Epithalon

Khavinson tetrapeptide

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally derived from the pineal gland peptide epithalamin.

§Dosing at a glance

2 protocols · from the research
What it's forDoseHow oftenHowFor how long
Animal (rodent) studies1 µgDailySubcutaneousInjected just under the skin, into the fat layer.5 days
Animal (rat) illumination/lifespan studies0.1 µgDailySubcutaneousInjected just under the skin, into the fat layer.4 mos

Approximate values pulled from the research — double-check before dosing.

§01Summary

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally derived from the pineal gland peptide epithalamin. It has attracted scientific interest primarily for its potential anti-aging properties, with research exploring its effects on cellular lifespan, hormonal regulation, and genomic stability. In early studies, Epitalon may extend maximum lifespan in multiple animal models12,14,16,17 and has been reported to restore age-related disruptions in melatonin production and cortisol rhythms in aging primates7,8. At the cellular level, it appears to activate telomerase — the enzyme responsible for maintaining chromosome ends — in human cell cultures6, and may support genomic stability by reducing chromosome aberrations in aging animals12,13. Preliminary evidence also suggests antioxidant activity, with early studies showing enhanced antioxidant enzyme expression in aged rats5. Epitalon has been explored in reproductive medicine contexts, where it may improve oocyte quality and embryo development in animal models1,15. Research into its potential role in neuronal differentiation4, metabolic normalization in aging primates8, and cancer biology10,11,16 is actively developing. Human evidence is currently emerging, with most mechanistic and efficacy data coming from animal and cell-based studies.

This is the layperson summary. Mechanism, dosing, the evidence base, and the published literature are in the sections below — every claim links to its source.

§02In depth

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide analog of epithalamin, a naturally occurring polypeptide isolated from the bovine pineal gland. Its molecular mechanism appears to operate through multiple convergent pathways centered on epigenetic gene regulation, telomerase activation, and neuroendocrine modulation.

The most mechanistically distinctive feature of Epitalon is its ability to interact directly with DNA and chromatin. Fluorescence-labeled Epitalon has been shown to penetrate the cell nucleus and nucleolus in HeLa cells, demonstrating sequence-specific binding to deoxyribooligonucleotides with preferential affinity for CNG- and CAG-containing sequences — sites relevant to cytosine methylation and epigenetic regulation2. Molecular docking studies suggest the peptide may also bind histone H1 subtypes at DNA-interacting regions, providing a proposed structural basis for its observed effects on neurogenic gene transcription4. Consistent with these molecular interactions, Epitalon induces deheterochromatinization of both facultative and pericentromeric structural heterochromatin in aged human lymphocytes, reactivating ribosomal genes and releasing age-repressed loci19,20. These epigenetic effects at the chromatin level may explain the transcriptional modulation of 22 brain transcripts involved in cell cycle regulation, apoptosis, and nucleic acid metabolism observed in mouse models18.

A second major mechanistic axis involves telomerase biology. Epitalon induces expression of the telomerase catalytic subunit (hTERT), stimulates telomerase enzymatic activity, and produces measurable telomere elongation in human fetal fibroblasts that normally lack telomerase activity6. In bovine reproductive models, Epitalon similarly activates telomerase, improves nuclear localization of the enzyme (a marker of cellular health), reduces reactive oxygen species, and enhances mitochondrial membrane potential in oocytes and cumulus cells1. In post-ovulatory aging mouse oocytes, it reduces spindle defects, increases mitochondrial DNA copy number, and decreases apoptosis through a mitochondria-mediated pathway15.

Neuroendocrine modulation represents a third functional axis. Epitalon stimulates evening melatonin synthesis in aged primates, normalizes cortisol circadian rhythmicity7, and restores age-related metabolic dysfunction including basal hyperglycemia and impaired glucose tolerance in old rhesus monkeys — effects that are absent in young animals, suggesting a homeostatic rather than pharmacologically forced mechanism8. Antioxidant activity has been demonstrated through upregulation of superoxide dismutase, glutathione peroxidase, and glutathione-S-transferase, as well as proposed transition metal chelation (Fe²⁺) as a contributing mechanism, in aged rat tissues5. Antimutagenic activity — demonstrated as statistically significant reductions in bone marrow chromosome aberrations in multiple mouse strains — appears mechanistically independent of melatonin pathways, as melatonin showed no comparable effect in parallel experiments13.

§04Evidence & efficacy

Evidence base
122Studies
32Human
63Animal

Epitalon's most replicated preclinical finding is extension of maximum lifespan and late-survivor lifespan in rodent models. In female SHR mice, maximum lifespan was extended by 12.3% and the last-decile mean lifespan by 13.3%12. In HER-2/neu transgenic mice, average and maximum lifespans were extended by approximately 13.5% and 13.9% respectively, alongside a 3.7-fold increase in tumor-free animals and a 1.6-fold reduction in lung metastases16. In rat lifespan studies under natural light conditions, maximum lifespan was extended by 95 days14. Lifespan extension of 11–16% was also reported in Drosophila melanogaster3.

Epitalon may reduce spontaneous tumor incidence in specific cancer-prone models. A 6-fold reduction in leukemia incidence was observed in SHR mice12, and significant inhibition of colon tumor multiplicity was reported in DMH-treated rats10,11. Tumor inhibition in rat studies appeared strongest with continuous treatment throughout the experiment10,11.

In aging primates, Epitalon may restore melatonin circadian rhythms and normalize glucose metabolism, including improved glucose tolerance and reduced basal hyperglycemia and hyperinsulinemia, with effects selective to aged animals7,8.

At the cellular level, Epitalon appears to induce telomerase activity and telomere elongation in human fetal fibroblasts6, reduce chromosome aberrations in multiple mouse strains by 17.9–30.1%13, and remodel chromatin in lymphocytes of elderly human subjects19,20. It may also improve oocyte quality and blastocyst development in bovine and mouse models1,15.

Early studies suggest Epitalon may stimulate neurogenic gene expression in human stem cells through proposed epigenetic mechanisms4 and modulates brain gene expression profiles related to cell cycle and apoptosis in mice18.

§05Safety

Across the reviewed studies, Epitalon appears to be well-tolerated in animal models with no reported adverse effects. Long-term subcutaneous administration in mice — spanning from early adulthood until death — was not associated with any observed effects on food consumption, body weight, or mean lifespan, and was described as appearing safe in that model12. Rat studies using 1 µg subcutaneously five times per week likewise reported no adverse events or tolerability issues10,11. Non-human primate studies in rhesus monkeys similarly reported no adverse findings7,8. No drug interactions or contraindications were identified in any reviewed study.

In vitro, Epitalon induces telomerase activity in normally telomerase-negative human somatic cells6 — a biological effect that ongoing research will help characterize in the context of long-term cellular physiology. Antioxidant and genomic stability data from animal models suggest a generally favorable cellular profile5,13. No human clinical safety or tolerability trials were identified among the reviewed studies.

§06History

Epitalon was developed from research into pineal gland peptides conducted primarily by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology in Russia, beginning in the 1980s and accelerating through the 1990s and 2000s. The compound is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed to replicate the bioactive core of epithalamin, a polypeptide extract of the bovine pineal gland that had demonstrated geroprotective properties in earlier Russian research programs.

Early published work established Epitalon's effects on lifespan extension in Drosophila melanogaster3 and its ability to restore neuroendocrine function in aging non-human primates7, laying a foundation for subsequent mammalian longevity studies. A landmark mechanistic finding emerged in 2003 when Khavinson and colleagues demonstrated telomerase induction and telomere elongation in human somatic cells, providing a molecular hypothesis for the peptide's proposed anti-aging activity6. Parallel lines of investigation through the early 2000s documented antimutagenic properties13, anti-tumor effects in multiple rodent models10,11,12,16, and chromatin remodeling in aged human lymphocytes19,20.

More recent research has expanded inquiry into reproductive medicine applications, with studies in bovine and mouse oocyte systems published through 2022–20251,15, and into neurogenic differentiation using human stem cells4. As of the mid-2020s, Epitalon continues to be an active subject of preclinical investigation, with human clinical trial data still emerging.

§07References